WHO ICTRP trial
High-dose therapy with Esomeprazol in combination with Baclofen therapy for…
EUCTR2006-000368-10-DE · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2006-000368-10-DE |
|---|---|
| Public title | High-dose therapy with Esomeprazol in combination with Baclofen therapy for symptomatic therapy-resistant gastrooesophageal reflux disease. - Nexbac |
| Scientific title | High-dose therapy with Esomeprazol in combination with Baclofen therapy for symptomatic therapy-resistant gastrooesophageal reflux disease. - Nexbac |
| Primary sponsor | Tecnical University of Munich |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Germany |
| Conditions | Gastroesophageal reflux disease |
| Interventions | Trade Name: Nexium 40mg Product Name: Esomeprazol Pharmaceutical Form: Powder and solvent for solution for infusion INN or Proposed INN: Esomeprazol Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 40… |
| Registration date | Jul 3, 2006 |
| Target size | 40 |
| Secondary IDs | NEX-426-MEI-0040-I |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: